Bio-Rad Laboratories, Inc. (BIO.B)
NYSE: BIO.B · Real-Time Price · USD
307.90
+23.02 (8.08%)
Oct 14, 2025, 4:00 PM EDT - Market closed
Bio-Rad Laboratories Market Cap
Bio-Rad Laboratories has a market cap or net worth of $8.15 billion as of October 14, 2025. Its market cap has decreased by -12.07% in one year.
Market Cap
8.15B
Enterprise Value
8.19B
1-Year Change
-12.07%
Ranking
Category
Stock Price
$307.90
Market Cap Chart
Since October 15, 2020, Bio-Rad Laboratories's market cap has decreased from $16.49B to $8.15B, a decrease of -50.55%. That is a compound annual growth rate of -13.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2025 | 8.34B | -9.34% |
| Dec 31, 2024 | 9.20B | -1.07% |
| Dec 29, 2023 | 9.30B | -25.52% |
| Dec 30, 2022 | 12.48B | -44.81% |
| Dec 31, 2021 | 22.62B | 30.09% |
| Dec 31, 2020 | 17.39B | 5.45% |
| Oct 15, 2020 | 16.49B | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.60B |
| Johnson & Johnson | 459.75B |
| AbbVie | 406.84B |
| UnitedHealth Group | 324.83B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 257.10B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.66B |